Skip to content

comparing the effects of nebulising dexmedetomidine in haemodynamic changes to intubation and postoperative sorethroat in patients undergoing general anaesthesia

Effect of nebulised dexmedetomidine in haemodynamic response to intubation and postoperative sorethroat in patients undergoing general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039739
Enrollment
12
Registered
2022-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H712- Cholesteatoma of mastoid Health Condition 2: H701- Chronic mastoiditis Health Condition 3: J320- Chronic maxillary sinusitis Health Condition 4: K119- Disease of salivary gland, unspecified Health Condition 5: K111- Hypertrophy of salivary gland Health Condition 6: C509- Malignant neoplasm of breast of unspecified site Health Condition 7: C55- Malignant neoplasm of uterus, partunspecified Health Condition 8: E042- Nontoxic multinodular goiter Health Condition 9:

Interventions

Intervention1: nebulisation: dexmedetomidine 1 microgram per kg body weight in 5 ml NS to one group and 5 ML normal saline to other group

Sponsors

DR THOMAS GEORGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA(American Society of Anaesthesiologist) Grade 1 ASA(American Society of Anaesthesiologist) Grade 2 Patients undergoing General Anaesthesia

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Haemodynamically compromised patients Emergency patients Patients on alpha and beta blocker Patients sensitive /allergic to study medication Patients with hyper-reactive airway

Design outcomes

Primary

MeasureTime frame
comparison of haemodynamic stress response such as heart rate, systolic blood pressure, diastolic blood pressure and mean arterial blood pressure will be measured before and after giving the nebulisation and the same is checked at every 1, 5, 10 minutes after the intubation . sore throat will be evaluated at 0,2,4,6,12 and 24h after extubation, during the post-operative period with dexmedetomidine and saline nebulisationTimepoint: 1 day

Secondary

MeasureTime frame
sore throat will be evaluated at 0,2,4,6,12 and 24h after extubation, during the post-operative period with dexmedetomidine and saline nebulisationTimepoint: 1 day

Countries

India

Contacts

Public ContactDR THOMAS P GEORGE

PUSHPAGIRI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE

doctorthomaspgeorge@gmail.com9447409620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026